Keyphrases
Positron Emission Tomography
100%
18F-fluorodeoxyglucose (18F-FDG)
44%
PET-MRI
44%
Attenuation Correction
38%
Total-body PET/CT
33%
MR-based Attenuation Correction
33%
Multi-parameter
33%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
33%
5-HT Release
33%
Positron Emission tomography-CT
33%
Clinical Setting
33%
Pediatric Brain Tumor
33%
Patient Assessment
33%
FDG Positron Emission Tomography
33%
C-11
33%
Image Artifacts
33%
Imaging Parameters
33%
Voxel-wise
33%
5-hydroxytryptamine
33%
Glioblastoma
33%
Brain Tumor Patients
33%
Receptor Occupancy
33%
Recurring
33%
Deep Learning Methods
33%
Pig Brain
33%
5-HT2A Receptor
33%
Tumor Recurrence
33%
Uptake Measurement
33%
CT Attenuation Correction
26%
Median Difference
22%
Radiotherapy Planning
22%
Radiotherapy
22%
Multiparametric Imaging
22%
Patient-specific
22%
Logistic Regression Model
22%
Contrast-enhancing Lesions
22%
Clinical Metrics
22%
SUVmax
18%
Relative Tumor Volume
18%
Positron Emission Tomography-computed Tomography (PET-CT)
16%
Tumor
15%
Medicine and Dentistry
Magnetic Resonance Imaging
66%
positron emission tomographic scan
66%
Polyethylene Terephthalate
58%
Fluorine-18
44%
Recurrent Disease
33%
Glioblastoma
33%
Pediatric Brain Tumor
33%
Reproducibility
33%
Tumor Recurrence
33%
Head and Neck Squamous Cell Carcinoma
33%
Whole Body PET
33%
Neoplasm
26%
Radiation Therapy
21%
Positron Emission Tomography-Computed Tomography
15%
Neuroscience
Magnetic Resonance Imaging
100%
Positron Emission Tomography
66%
positron emission tomographic scan
66%
Fluorine-18
37%
5-HT2A Receptor
33%
Pediatric Brain Tumor
33%
Receptor Occupancy
33%
Radiation Therapy
33%
